AI And Therapeutic Antibody Design

A test of 511 AI-designed antibodies found that AI can improve promising drug candidates, but laboratory experiments remain essential for discovering safe, developable antibodies, according to Forbes contributor William A. Haseltine. The finding indicates AI can refine antibody leads while human-run lab validation stays necessary for safety and developability.

AI And Therapeutic Antibody Design By William A. Haseltine, ContributorSource: Forbes Innovation https://www.forbes.com/innovation/ A test of 511 AI-designed antibodies shows AI can improve promising drug candidates, but lab experiments remain essential for discovering safe, developable antibodies. Get AI news in your inbox Daily digest of what matters in AI.